The purpose of this proposal is to determine the effects of protease inhibitors in the abrogation of invasion by human bladder tumor cells. To study the biochemical mechanisms of bladder tumor invasion, we have previously analyzed invasive transitional cell carcinoma cell line EJ and non-invasive transitional cell carcinoma cell line RT4 which had been implanted into the bladders of nude mice. Our results demonstrated that cathepsin B, a cysteine proteinase which has the ability to degrade basement membrane laminin, is found in the plasma membrane of invasive tumor cells whereas non-invasive tumor cells have cathepsin B confined to their lysosomes. This suggests that cathepsin B is redistributed and may be used by invasive cells to degrade basement membrane components. Our finding further suggests that protease inhibitors may play a significant role in limiting the invasive potential of human bladder tumor cells. In this proposal, we will determine the effects of cysteine proteinase inhibitors in inhibiting the activity of plasma membrane bound cathepsin B at a biochemical level using enzyme overlay membranes and isoelectric focusing of subcellular fractions. Furthermore, we will determine the effects of proteinase inhibitors in inhibiting the degradation of laminin, a basement membrane component, by membrane bound cathepsin B. After our initial biochemical analyses, we will determine the effects of proteinase inhibitors in inhibiting the invasion of human bladder tumor cells through an in vitro artificial basement membrane. And finally, we will develop an in vivo model to determine the effects of protease inhibitors in bladder tumor invasion. We will attempt in these studies to determine not only the possible effectiveness of such intervention at a biochemical, cellular, and in vivo level, but also address the fundamental biochemical mechanisms of tumor cell invasion.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA051968-02
Application #
3196727
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1991-04-01
Project End
1994-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Woo, K R; Shu, W P; Kong, L et al. (1996) Tumor necrosis factor mediates apoptosis via Ca++/Mg++ dependent endonuclease with protein kinase C as a possible mechanism for cytokine resistance in human renal carcinoma cells. J Urol 155:1779-83
Margolis, E J; Choi, J C; Shu, W P et al. (1996) Specific sequences of fibronectin activate the protein kinase C signal transduction pathway in invasive bladder cancer. Cancer Lett 100:163-8
Miniati, D N; Chang, Y; Shu, W P et al. (1996) Role of prostatic basal cells in the regulation and suppression of human prostate cancer cells. Cancer Lett 104:137-44
Ostad, M; Shu, W P; Kong, L et al. (1996) Ha-ras oncogene expression abrogates a pH dependent endonuclease activity of apoptosis in normal rat kidney cells. Cancer Lett 98:175-82
Robbins, S E; Shu, W P; Kirschenbaum, A et al. (1996) Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells. Prostate 29:362-70
Shemtov, M M; Cheng, D L; Kong, L et al. (1995) LAK cell mediated apoptosis of human bladder cancer cells involves a pH-dependent endonuclease system in the cancer cell: possible mechanism of BCG therapy. J Urol 154:269-74
Cheng, D L; Shu, W P; Choi, J C et al. (1994) Bacillus Calmette-Guerin interacts with the carboxyl-terminal heparin binding domain of fibronectin: implications for BCG-mediated antitumor activity. J Urol 152:1275-80
Liu, B C; Liotta, L A (1992) Biochemistry of bladder cancer invasion and metastasis. Clinical implications. Urol Clin North Am 19:621-7
Redwood, S M; Liu, B C; Weiss, R E et al. (1992) Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s). Cancer 69:1212-9
Garden, R J; Liu, B C; Redwood, S M et al. (1992) Bacillus Calmette-Guerin abrogates in vitro invasion and motility of human bladder tumor cells via fibronectin interaction. J Urol 148:900-5

Showing the most recent 10 out of 12 publications